Evidence-Based Field Communication
“You have the data, but your reps can't use it.”
A structured evidence-to-field program that translates the evidence base into scientifically accurate, regulation-compliant, non-technical field communication.
Typical Deliverables
The Problem
Field teams often lack the scientific literacy to interpret clinical evidence correctly or stay within regulatory boundaries when discussing outcomes with physicians. Reps who can't answer clinical questions lose credibility; reps who overstate claims create regulatory exposure. The gap is not in how the team communicates, but in what they understand about the evidence.
The Approach
A structured evidence-to-field program starts with the science and ends with practical tools the team can use in the field. The process is systematic:
- Identify the key clinical questions per product and indication
- Consult the full body of evidence (internal data + published literature)
- Conduct or summarize the relevant meta-analyses
- Translate findings into plain language with regulation-compliant claims
- Train the field team to use these materials with confidence
This is evidence-based communication training led by a PhD-level clinical scientist — not conventional sales coaching. The person who understands the statistical methods, the regulatory framework, and the clinical context is the same person translating it for the field.
For companies that have completed a post-market clinical roadmap, the evidence-based field communication program builds directly on that work — same evidence base, same claims matrix, translated for a different audience. The person who built the evidence is the same person translating it for the field, ensuring complete consistency between regulatory documentation and field messaging.
Service Catalog
Evidence-to-Field Translation
Systematic translation of clinical evidence into field-ready materials. Starting from the raw evidence (clinical studies, CERs, literature reviews, meta-analyses), key findings are distilled into plain-language summaries with regulation-compliant claims. Every statement is traceable to a specific data source and verified against the regulatory documentation to ensure compliance.
Product & Indication Evidence Dossiers
Comprehensive evidence dossiers organized by product and indication. Each dossier contains: a summary of the clinical evidence, key efficacy and safety data, comparison with competitor products (where published data allows), answers to anticipated clinical questions, and clear guidance on what can and cannot be claimed. Designed as working reference documents for field teams — not marketing brochures.
Training Workshops
Structured 1-day live training workshops or virtual sessions for sales representatives, combining didactic sessions on clinical evidence interpretation with interactive case-based exercises using actual product data. Topics include: reading and interpreting clinical studies, statistical significance vs. clinical relevance, handling physician questions about evidence, and regulatory boundaries for field communication. Follow-up refresher modules reinforce learning as new evidence becomes available.
Key Clinical Question Mapping
Systematic identification and mapping of the clinical questions that physicians and procurement committees ask about a product. For each question: the evidence-based answer, the supporting data source, the confidence level of the evidence, and the regulatory-compliant way to communicate the finding — forming the foundation for all field communication materials and training content.
Quick-Reference Evidence Cards
Pocket-sized reference cards for field use, summarizing the key evidence points for each product and indication. Each card contains: the clinical claim, the supporting data (with citation), the confidence level, and a plain-language explanation suitable for physician conversations — practical tools built to be carried and consulted during sales calls, not marketing collateral.
Claims Matrix Alignment
Verification that all field communication materials are aligned with the documented, evidence-supported claims in the regulatory files — ensuring that what the field team says in the hospital is consistent with what the CER states and what the notified body has reviewed. Any discrepancies are flagged and resolved before materials are released to the field.
Who This Is For
Medical device companies with a strong clinical evidence base that is not being effectively communicated in the field. Particularly relevant for companies with complex products (implants, surgical devices, diagnostic systems) where physician conversations require scientific depth beyond standard marketing materials.
Ready to translate your evidence into field-ready communication?
Contact